Discover 188 paid clinical trials in Vermont. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Vermont offers a variety of opportunities for both healthy volunteers interested in taking part in paid studies and those with specific health conditions. Research centers in Burlington, Rutland, and Montpelier are actively recruiting, granting access to cutting-edge therapies and innovative medical care.
Filter
1
Filter results
Results: 188
Active & Responsive
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
for
Primary Central Nervous System Lymphoma
Location: 5 recruiting locations
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT06175000
Phase2, Recruiting
Active & Responsive
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
for
Generalized Myasthenia Gravis
Location: 14 recruiting locations
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Sex: All
Age: 18+
Code: NCT06463587
Phase3, Recruiting
Active & Responsive
IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
for
Nontuberculous Mycobacterium Infection
Location: 10 recruiting locations
Sponsor: Chris Goss
Sex: All
Age: 18+
Code: NCT04294043
Phase1, Recruiting
Active & Responsive
Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes
for
Tobacco Use Disorder
Location: 2 recruiting locations
Sponsor: University of Vermont
Sex: All
Age: 21+
Code: NCT06614504
Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
for
Calcific Aortic Valve Disease
Location: 24 recruiting locations
Sponsor: REDNVIA Co., Ltd.
Sex: All
Age: 35+
Code: NCT05143177
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease